Navigation Links
Manchester clears first hurdle in €170 million biobank building boom
Date:6/19/2008

The University of Manchester has been successful in gaining major European Union funding to begin joint planning of how millions of biological samples, such as DNA, can be managed and made available to research scientists across Europe.

The Centre for Integrated Genomic Medical Research (CIGMR), based in the School of Translational Medicine, is playing a key role in developing the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) alongside scientists and funding agencies in other European member states.

This infrastructure will link new and existing biobanks across the continent and planners anticipate the cost of construction will exceed 170 million.

The initial planning phase will last two years and cost 5 million, the sum announced today (Thursday). It will answer key questions, including whether the infrastructure will comprise a number of physical buildings in locations across Europe or whether a virtual infrastructure would be the best option, or a combination of both.

Dr Martin Yuille, Reader in Biological Resource Management and associate coordinator for the planning phase, said: "This European biobanking infrastructure is as important to biomedical science as CERN is to Physics or Jodrell is to Astronomy.

"It will counter fragmentation in Europe that is impeding access to valuable resources essential for translating the human genome sequence into health benefits."

Advances in robotics, miniaturisation and imaging are allowing detailed molecular analysis of biological samples. For biomedicine this means that samples from very large numbers of patients and healthy individuals need to be studied to discover, for example, the genes that underlie our risk of diseases like heart disease, cancer or Alzheimer's.

Manchester is already a leading centre for this area of research. It is host to the UK Biobank - a world-leading study of how genes and lifestyle contribute to health
'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Page: 1 2

Related biology news :

1. Queens University launches UKs first Center of Excellence for Public Health
2. First successful reverse vasectomy on endangered species performed at the National Zoo
3. Professor Brian Greenwood awarded first Hideyo Noguchi Africa Award
4. Leiden scientists sequence first female DNA
5. Precourt Institute for Energy Efficiency awards first faculty research grants
6. IEEE Fellow first woman to receive highest award in engineering profession
7. Pioneering landscape-scale research releases first findings
8. BIO-key(R) Reports First Quarter 2008 Results
9. Scientists decipher fruit tree genome for the first time
10. BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule
11. First analysis of platypus genome may impact disease prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "Global Facial Recognition Market ... http://photos.prnewswire.com/prnh/20130307/600769 Facial ... of individuals. Facial recognition system measures the overall ... jaw edges, mouth, and the distance between eyes. ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San Diego ... that provides the connective tissue that enhances care coordination ... to easily share client-level information; earned a second $1 ... to organizations serving seniors aging in community and; will ... on December 11 th 4-6p. CIE ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... In a multifaceted study involving the Kuna Indians ... pinpointed a chemical compound that is, in part, ... and some chocolate products. , The researchers, who ... Heinrich-Heine University of Duesseldorf, Germany; and Harvard Medical ...
... using a toothbrush, the Norwegians found one using a drill. The ... Sea, at an entire 2256 metres below the seabed. It had ... the North Sea wasn't a sea at all, but an enormous ... of the old dinosaur now see the light of day again, ...
... against not only multi drug-resistant forms of the disease but ... stage of infection as well. Researchers report their results ... class of which this compound is the lead has a ... used to treat tuberculosis. We have identified no cross ...
Cached Biology News:Heart-healthy compound in chocolate identified 2Experimental TB drug effective against resistant and latent mycobacterium tuberculosis 2
(Date:12/15/2014)... 15, 2014  Origin Agritech Limited (NASDAQ GS: SEED) (" ... of crop seeds in China , today ... year 2014 ended September 30, 2014, before the market opens ... host a teleconference on January 8, 2015, at 8:00 a.m. ... to discuss the results. To participate in the call, please ...
(Date:12/13/2014)... N.C. (PRWEB) December 13, 2014 CanDiag, ... Charlotte) spin-out company has changed its name to OncoTab, ... accurate representation of where we are today,” said CEO ... extended our platform’s applications beyond breast cancer diagnostics to ... a reflection of that evolution.” , Founded in 2011 ...
(Date:12/13/2014)... 2014 Clarassance, a privately held clinical-stage ... name: Therabron Therapeutics , Inc. The new name ... type of structure in the lungs similar to branches ... develop novel protein therapeutics for the treatment of respiratory ... change the name to mark the company's escalation into ...
(Date:12/13/2014)... Taiwan (PRWEB) December 12, 2014 Trend ... indicators in overall global economic growth, Eugene Arthurs, CEO ... photonics , said in a featured talk at OPTIC ... December at the National Chung Hsing University in Taichung. ... being integrated into future energy supplies and soon to ...
Breaking Biology Technology:Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 2Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 3Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 4Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 5
... SAN FRANCISCO, Calif., March 5 Poniard Pharmaceuticals, ... company focused on innovative oncology therapies, today announced ... discuss the Company,s fourth quarter and year-end financial ... development activities for picoplatin, the Company,s lead product ...
... Proteon Therapeutics, Inc., announced today that it has successfully ... by MPM Capital on behalf of the MPM Bio ... the initiation of a Phase 1/2 human clinical study ... stage renal disease undergoing surgery for arteriovenous fistula (AVF) ...
... - Proceeds to Facilitate Clinical Development of ... a pioneer in the development of innovative conjugated,vaccines, today ... million, EUR17 million) Series B financing. The round was ... Ventures and,Sofinnova Partners, expressed their commitment to the future ...
Cached Biology Technology:Poniard Pharmaceuticals to Host Fourth Quarter and Year-End 2008 Financial Results Conference Call on March 12 2Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company 2GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners 2
...
...
with GlutaMAXIL-glutamine...
... GOAT ANTI-MOUSE IgG+IgA+IgM (H+L) ... with highly purified horseradish ... antibody has been absorbed ... fetal bovine, horse, goat, ...
Biology Products: